Has David Klein, MD received payments from drug or device companies?

Yes. Drug and device makers reported $879 in general payments to David Klein, MD across 51 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean David Klein, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about David Klein, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

David Klein, MD

Psychiatry · Atlanta, GANPI 1790962942

Payments from drug & device makers

$879in general payments, 2019–2025

Across 51 payments — averaging $17.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Takeda Pharmaceuticals U.S.A., Inc.$185
Lundbeck LLC$152
Johnson & Johnson$126
Shire North American Group Inc$111
Otsuka America Pharmaceutical, Inc.$72
Neos Therapeutics, LP$57
plus $176 from 7 others

What the payments were for

Food & beverage$86699%
Education$131%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Takeda Pharmaceuticals U.S.A., Inc.	9	$185
Lundbeck LLC	8	$152
Johnson & Johnson	10	$126
Shire North American Group Inc	7	$111
Otsuka America Pharmaceutical, Inc.	4	$72
Neos Therapeutics, LP	3	$57
Ironshore Pharmaceuticals Inc.	2	$36
AbbVie	2	$32
Arbor Pharmaceuticals, Inc.	2	$27
Vanda Pharmaceuticals Inc.	1	$24
Neurocrine Biosciences, Inc.	1	$22
Avanir Pharmaceuticals, Inc.	1	$19
Adlon Therapeutics L.p.	1	$16

How this compares

$879 in reported general payments places this provider in the 60th percentile of 900 psychiatry providers in Georgia.

See all psychiatry providers in Georgia →

Medicare billing

Part B allowed, 2024

$4,732

Medicare patients

Services billed

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Lurasidone Hcl	15	$21,441
Vilazodone Hcl	12	$2,247
Paliperidone ErPaliperidone	13	$1,603
Bupropion XlBupropion Hcl	41	$771
Ziprasidone Hcl	11	$671
Quetiapine Fumarate	15	$647
Divalproex Sodium ErDivalproex Sodium	14	$492
Aripiprazole	12	$454
Prazosin Hcl	11	$411
Duloxetine Hcl	25	$369
Gabapentin	11	$226
Buspirone Hcl	12	$219
Clonazepam	39	$206
Escitalopram Oxalate	30	$177
Trazodone Hcl	18	$158

Paid to pharmacies, not to this prescriber.

Other psychiatry in Atlanta

Robert RiesenbergAtlanta$51.1M
Saundra Maass-RobinsonAtlanta$11.1M
David PurselleAtlanta$7.4M
Bethany DavisAtlanta$4.4M
Patricio Riva PosseAtlanta$884K
Kerry ResslerAtlanta$365K
Boadie DunlopAtlanta$345K
Michael BurkeAtlanta$328K
Bryon EvansAtlanta$211K
Nurul HoqueAtlanta$145K

See the full list for Georgia →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →